NEW YORK – Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at… Read More
Frontage is pleased to announce the appointment of Mr. Henry Gao as President of Asia Pacific. Mr. Gao possesses more than 25 years of experience in leading various functions including… Read More
Dr. Yaodong Huang, PhD joins ACME Bioscience, a Frontage Laboratories Inc company with over 15 years of experience in medicinal chemistry and organic synthesis. He had previously worked for ACME… Read More
Frontage Laboratories, Inc. announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera)…. Read More
VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, announced that Maureen O’Connell has stepped down from her position as Director and Audit… Read More
